Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the
development of dementia. Despite the importance of early identification of mild cognitive …

The recent formalization of clinical criteria for Parkinson's disease with dementia (PDD)
codifies many studies on this topic, including those assessing biological correlates. These …

Introduction Parkinson's disease dementia (PDD) is associated with poorer quality of life
(QoL). Prior to the onset of PDD, many patients experience progressive cognitive …

Dementia can occur in a substantial number of patients with Parkinson's disease with a point
prevalence close to 30%. The cognitive profile is characterized by predominant deficits in …

Abstract Introduction In PD, Mild Cognitive Impairment (PD-MCI) occurs since early stages of
disease. The aims were to assess presence of PD-MCI in untreated, drug-naive PD patients …

ABSTRACT Background The International Parkinson and Movement Disorder Society
criteria for mild cognitive impairment in PD were recently formulated. Objectives The aim of …

Mild cognitive changes, including executive dysfunction, are seen in Parkinson's Disease
(PD). Approximately 30% of individuals with PD develop Parkinson's disease dementia …

Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by
motor symptoms such as rigidity, rest tremor, and bradykinesia. However, a growing body of …

Approximately 30% of Parkinson's disease (PD) patients show impaired cognitive
performance, which is suggestive of Mild Cognitive Impairment (MCI), representing a …

Background The optimal properties of a comprehensive (level II) neuropsychological battery
for determining Parkinson's disease mild cognitive impairment (PD‐MCI) by Movement …